- Previous Close
0.0250 - Open
0.0200 - Bid 0.0150 x --
- Ask 0.0250 x --
- Day's Range
0.0200 - 0.0250 - 52 Week Range
0.0050 - 0.0300 - Volume
230,040 - Avg. Volume
44,918 - Market Cap (intraday)
7.715M - Beta (5Y Monthly) 6.95
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0100 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Universal Ibogaine Inc., a life sciences company, develops, acquires, and operates addiction treatment clinics in Canada. The company undertakes planned clinical trial for research into the use of ibogaine for addiction treatment. The company is headquartered in Calgary, Canada.
universalibogaine.comRecent News: IBO.V
View MorePerformance Overview: IBO.V
Trailing total returns as of 4/8/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: IBO.V
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: IBO.V
View MoreValuation Measures
Market Cap
7.72M
Enterprise Value
10.25M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.10
Price/Book (mrq)
11.94
Enterprise Value/Revenue
4.85
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-103.62%
Return on Assets (ttm)
-13.58%
Return on Equity (ttm)
-190.63%
Revenue (ttm)
2.11M
Net Income Avi to Common (ttm)
-2.19M
Diluted EPS (ttm)
-0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
91.83k
Total Debt/Equity (mrq)
406.56%
Levered Free Cash Flow (ttm)
-935.09k